Aster DM Quality Care
Stock Snapshot
Price Performance
Vista Outlook
View Technicals Analysis →Basis of our Recommendation
Aster DM Quality Care is navigating a transformative phase following its merger with Quality Care India Ltd., which is expected to unlock significant operational synergies and enhance its competitive position in the Indian healthcare market. Management's focus on integrating the two entities aims to achieve a 10-15% uplift in EBITDA, supported by a robust expansion plan targeting over 4,000 new beds by FY30. The company reported a strong Q1 performance with 22% revenue growth, driven by high-end tertiary procedures and improved operational efficiencies. Vista's financial outlook reflects this momentum, projecting accelerating revenue growth and stable margins, with a target price indicating an expected upside of approximately 28.8%. However, execution risks related to the merger integration and competitive pressures in urban markets remain critical watchpoints. The healthcare sector's favorable dynamics, including rising insurance coverage and demand for quality services, further bolster Aster's growth prospects, despite potential headwinds from margin pressures and regulatory challenges. Over the next 12-24 months, Aster DM's ability to successfully integrate operations and scale occupancy in new facilities will be pivotal for sustaining its growth trajectory
Why We Like This Stock
- Successful merger integration is expected to yield 10-15% EBITDA synergies, enhancing profitability
- Strong Q1 performance with 22% revenue growth indicates robust demand for high-end healthcare services
- A comprehensive expansion plan targeting over 4,000 new beds by FY30 supports long-term growth potential
Things To Watch Out For
- Execution risks related to the merger integration could impact operational performance
- Competitive pressures in urban markets may challenge margin stability
- Potential regulatory changes and supply chain disruptions could affect future earnings
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 3,699 | 4,138 | 4,643 | 5,093 | 6,707 |
| Profit Before Tax (Cr.) | 261 | 512 | 603 | 746 | 967 |
| PBT Margin | 7.1% | 12.4% | 1298.7% | 14.6% | 14.4% |
| Net Profit (Cr.) | 235 | 310 | 409 | 502 | 589 |
| Earnings Per Share | 3.0 | 5.4 | 7.1 | 8.8 | 11.4 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| Elara Capital | ► Accumulate | 736 | 02-May-2026 |
| HDFC Securities | ► Add | 910 | 06-Aug-2026 |
| HSBC | ▲ Buy | 785 | 04-May-2026 |
| ICICI Securities | ► Hold | 855 | 06-Aug-2026 |
| Prabhudas Liladhar | ▲ Buy | 920 | 06-Aug-2026 |
Company Overview
Show Company Profile
Aster DM Quality Care Limited operates as an integrated healthcare provider in India. The company operates through four healthcare brands including Aster DM, CARE Hospitals, Evercare, and KIMSHEALTH. It offers comprehensive healthcare services including primary, secondary, tertiary and quaternary care across key areas including oncology, cardiac sciences, neurosciences, gastro sciences, orthopedics, nephrology, organ transplantation, mother and childcare, and critical care. In addition, the company operates retail pharmacies and optical outlets. Aster DM Quality Care Limited was formerly known as Aster DM Healthcare Limited and changed its name to Aster DM Quality Care Limited in July 2026. The company was founded in 1987 and is based in Bengaluru, India.